Logo image of GPUS

HYPERSCALE DATA INC (GPUS) Stock Fundamental Analysis

NYSEARCA:GPUS - NYSE Arca - US09175M8047 - Common Stock - Currency: USD

4.99  +0.14 (+2.89%)

After market: 4.95 -0.04 (-0.8%)

Fundamental Rating

2

Overall GPUS gets a fundamental rating of 2 out of 10. We evaluated GPUS against 6 industry peers in the Industrial Conglomerates industry. GPUS has a bad profitability rating. Also its financial health evaluation is rather negative. GPUS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

GPUS had negative earnings in the past year.
GPUS had a negative operating cash flow in the past year.
In the past 5 years GPUS always reported negative net income.
In the past 5 years GPUS reported 4 times negative operating cash flow.
GPUS Yearly Net Income VS EBIT VS OCF VS FCFGPUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -27.85%, GPUS is doing worse than 83.33% of the companies in the same industry.
GPUS has a Return On Equity of -711.92%. This is in the lower half of the industry: GPUS underperforms 66.67% of its industry peers.
Industry RankSector Rank
ROA -27.85%
ROE -711.92%
ROIC N/A
ROA(3y)-45.99%
ROA(5y)-36.36%
ROE(3y)-439.95%
ROE(5y)-278.29%
ROIC(3y)N/A
ROIC(5y)N/A
GPUS Yearly ROA, ROE, ROICGPUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600

1.3 Margins

GPUS has a better Gross Margin (23.17%) than 66.67% of its industry peers.
GPUS's Gross Margin has improved in the last couple of years.
GPUS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.3%
GM growth 5Y10.66%
GPUS Yearly Profit, Operating, Gross MarginsGPUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

2

2. Health

2.1 Basic Checks

GPUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GPUS has been increased compared to 1 year ago.
Compared to 5 years ago, GPUS has more shares outstanding
Compared to 1 year ago, GPUS has a worse debt to assets ratio.
GPUS Yearly Shares OutstandingGPUS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
GPUS Yearly Total Debt VS Total AssetsGPUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

GPUS has an Altman-Z score of -4.77. This is a bad value and indicates that GPUS is not financially healthy and even has some risk of bankruptcy.
With a decent Altman-Z score value of -4.77, GPUS is doing good in the industry, outperforming 66.67% of the companies in the same industry.
GPUS has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
GPUS has a better Debt to Equity ratio (0.10) than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z -4.77
ROIC/WACCN/A
WACC10.34%
GPUS Yearly LT Debt VS Equity VS FCFGPUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

2.3 Liquidity

A Current Ratio of 0.27 indicates that GPUS may have some problems paying its short term obligations.
GPUS has a worse Current ratio (0.27) than 83.33% of its industry peers.
A Quick Ratio of 0.26 indicates that GPUS may have some problems paying its short term obligations.
The Quick ratio of GPUS (0.26) is worse than 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.27
Quick Ratio 0.26
GPUS Yearly Current Assets VS Current LiabilitesGPUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 97.35% over the past year.
The Revenue for GPUS has decreased by -23.00% in the past year. This is quite bad
GPUS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.68% yearly.
EPS 1Y (TTM)97.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.96%
Revenue 1Y (TTM)-23%
Revenue growth 3Y26.73%
Revenue growth 5Y36.68%
Sales Q2Q%-46.75%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GPUS Yearly Revenue VS EstimatesGPUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
GPUS Yearly EPS VS EstimatesGPUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 -5K -10K -15K

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GPUS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GPUS Price Earnings VS Forward Price EarningsGPUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GPUS Per share dataGPUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for GPUS!.
Industry RankSector Rank
Dividend Yield N/A

HYPERSCALE DATA INC

NYSEARCA:GPUS (6/3/2025, 8:04:01 PM)

After market: 4.95 -0.04 (-0.8%)

4.99

+0.14 (+2.89%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)04-15 2025-04-15
Earnings (Next)N/A N/A
Inst Owners2.77%
Inst Owner Change-9%
Ins Owners0.08%
Ins Owner Change-1.72%
Market Cap36.03M
Analysts82.86
Price TargetN/A
Short Float %16.63%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.98
Dividend Growth(5Y)N/A
DP-8.58%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.29
P/FCF N/A
P/OCF N/A
P/B 4.17
P/tB 5.3
EV/EBITDA N/A
EPS(TTM)-64.18
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-3.36
FCFYN/A
OCF(TTM)-2.69
OCFYN/A
SpS17.15
BVpS1.2
TBVpS0.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.85%
ROE -711.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.17%
FCFM N/A
ROA(3y)-45.99%
ROA(5y)-36.36%
ROE(3y)-439.95%
ROE(5y)-278.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.3%
GM growth 5Y10.66%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 19.76%
Cap/Sales 3.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.27
Quick Ratio 0.26
Altman-Z -4.77
F-Score5
WACC10.34%
ROIC/WACCN/A
Cap/Depr(3y)200.34%
Cap/Depr(5y)1362.93%
Cap/Sales(3y)34.08%
Cap/Sales(5y)78.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-23%
Revenue growth 3Y26.73%
Revenue growth 5Y36.68%
Sales Q2Q%-46.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-71.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-257.61%
OCF growth 3YN/A
OCF growth 5YN/A